Fabio Cominelli, MD, PhD

Showing   of 6 results


Research Discoveries Boost Personalized Treatment for IBD

Fabio Cominelli, MD discusses how his team of researchers discovered the specific blockade of interleukin-18 can reduce disease severity in colitis and new personalized therapies to put IBD in permanent remission.

Does the Microbiome Hold the Key to Treating Inflammatory Bowel Disease?

Gut instincts - Innovations in Digestive Health | Winter 2020

Suppressing Inflammation in IBD Patients

UH Digestive Health Institute explores new IBD treatment using IL-1 targeted therapy UH Innovations in Digestive Health - Fall 2018  Fabio Cominelli, MD For 25 years, researchers have studied interleukin-1 (IL-1), a highly active proinflammatory...

Investigating Treatments for Inflammatory Bowel Disease

UH Inflammatory Bowel Disease Center advances clinical research and therapies to treat Crohn's disease and ulcerative colitis UH Digestive Health Institute - Winter 2018  Fabio Cominelli, MD, PhD  Maneesh Dave, MD, MPH  Jeffrey Katz, MD A...

Excellence in Leading Edge Crohn's Disease Research

UH Digestive Disease Institute | Janaury 2017

UH Gastroenterologist Leading New NIH-Funded Digestive Diseases Research Core Center

Innovative care for Inflammatory and Metabolic Digestive Disease UH Digestive Health Institute - January 2016  Fabio Cominelli, MD, PhD Fabio Cominelli, MD, PhD, Chief Scientific Officer, UH Digestive Health Institute; Chief, Division of...

Results are loading...